We are live on ! Find out more
OM icon

Outset Medical

73 hedge funds and large institutions have $23.4M invested in Outset Medical in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more call options, than puts

Call options by funds: $159K | Put options by funds: $73K

6% less funds holding

Funds holding: 78 → 73 (-5)

9.95% less ownership

Funds ownership: 50.02% → 40.07% (-10%)

33% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 24

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

68% less capital inflows, than outflows

Capital inflows: $1.64M | Capital outflows: $5.11M

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
16
Reduced
24
Closed
16
Calls
$159​K
Puts
$73​K
Net Calls
+$86​K
Net Calls Change
+$85​K

OM Hedge Fund Activity: Q4 2024 in Review

73 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2024, worth a combined $23.4M — up 33% from $17.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OM and 7 opened new positions — a net loss of 9 holders — while 24 trimmed existing stakes and 16 added.

The largest buyer was Renaissance Technologies, adding an estimated $526K. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.

  • 73 institutional investors held Outset Medical (OM) as of Q4 2024, down from 78 in Q3 2024.
  • Funds reported $23.4M of Outset Medical stock for Q4 2024, up 33% quarter-over-quarter.
  • 7 funds opened new Outset Medical positions in Q4 2024 and 16 closed out, a net change of -9 holders.
  • The largest Outset Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $526K added.
  • The largest Outset Medical seller in Q4 2024 was Ameriprise, an estimated $1.23M sold.

Based on aggregated 13F filings for Q4 2024.